Led by the UPC’s Centre for Sensors, Instruments and Systems Development, an international consortium of universities, hospitals and companies is developing new technologies based on light and AI to improve the diagnosis of several diseases.
FDA admonishes Jiangsu Hengrui’s manufacturing site following inspection – Pharmaceutical Technology
Concerns over Jiangsu’s facilities come ahead of the US’s preparations to launch the BIOSECURE Act. Credit: grandbrothers via Shutterstock. The US Food and Drug Administration